Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 4Genitourinary 2Gastrointestinal 2Other solid neoplasm 1Head & Neck 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Mesothelioma, Malignant 2Unspecified Adult Solid Tumor, Protocol Specific 1Small Cell Lung Carcinoma 1Pancreatic Neoplasms 1Lung Neoplasms 1Kidney Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Cyclophosphamide 6pembrolizumab 5Cisplatin 4sargramostim 3Pemetrexed 3Decitabine 3Celecoxib 3fludarabine 2belinostat 2SS1(dsFv)PE38 2Quality of Life 2Plicamycin 2Nivolumab 2Ipilimumab 2FANG vaccine 2Drug Therapy 2perflutren 1olaparib 1niraparib 1iodixanol 1incomplete Freund's adjuvant 1fludarabine phosphate 1dostarlimab 1anetumab ravtansine 1aldesleukin 1alanosine 1Vorinostat 1Valacyclovir 1UV1 vaccine 1Tumor Burden 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Interferon-alpha × Other solid neoplasm × Clear all
NCT00002475 2013-07-10

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

National Cancer Institute (NCI)

Phase 2 Completed
40 enrolled
BreastGastrointestinalGenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡